Cryptococcal lung disease in patients without HIV infection

Chest

Volumn 115, Issue 3, 1999, Pages 610-611

  Sarosi, G A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; KETOCONAZOLE;

BODY TEMPERATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR PUNCTURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MENINGITIS; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032990706     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.3.610     Document Type: Editorial

References (6)

1. RA Larsen Cryptococal meningitis in persons with AIDS GA Sarosi SF Davies Fungal diseases of the lung 2nd ed. 1993 Raven Press, Ltd New York, NY 237 245
2. TM Kerkering RJ Duma S Shadomy The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors Ann Intern Med 94 1981 611 616
3. PG Pappas J Perfect RA Larsen Cryptococcosis in HIV-negative patients: analysis of 306 cases [abstract] Clin Infect Dis 27 1998 939
4. ER Block AE Jennings JE Bennett 5-fluorocytosine resistance in Cryptococcus neoformans Antimicrob Agents Chemother 3 1973 649 656
5. JE Bennett WE Dismukes RJ Duma A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis N Engl J Med 301 1979 126 131
6. MS Saag WG Powderly GA Cloud Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis N Engl J Med 326 1992 83 89